SCHEMBL477385

SCHEMBL477385

Cc1ccc([C@H](O)c2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.50
MLKL Q8NB16 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.48
TSHR P16473 2/20 0.48
ALOX12 P18054 1/20 0.48
ACHE P22303 1/20 0.48
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
HSD17B10 Q99714 1/20 0.45
KEAP1 Q14145 1/20 0.45
NFE2L2 Q16236 1/20 0.45
CNR2 P34972 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL477533 1.00 LMNA (0.50) LMNAMLKLSMN1; SMN2TSHRALOX12
SCHEMBL477590 1.00 LMNA (0.50) LMNAMLKLSMN1; SMN2TSHRALOX12
SCHEMBL3863823 0.93 CA12 (0.55) LMNAMLKLSMN1; SMN2CYP3A4CYP2D6
SCHEMBL96180 0.89 ACHE (0.50) LMNAMLKLTSHRACHECYP3A4
Hydrochloric Acid SCHEMBL29699724 0.87 ACHE (0.47) LMNAMLKLTSHRACHECYP3A4
SCHEMBL8671295 0.87 SMN1; SMN2 (0.58) LMNASMN1; SMN2TSHRCYP2D6CA12
SCHEMBL12378742 0.86 LMNA (0.41) LMNAMLKLSMN1; SMN2TSHRCYP3A4
SCHEMBL6878032 0.85 LMNA (0.54) LMNATSHRALOX12ACHECYP3A4
Diphenylmethanol SCHEMBL6434457 0.84 SMN1; SMN2 (0.61) LMNASMN1; SMN2TSHRCYP2D6CA12
Diphenylmethanol SCHEMBL11564700 0.84 SMN1; SMN2 (0.61) LMNASMN1; SMN2TSHRCYP2D6CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2785688-B1 A PROCESS FOR THE MANUFACTURE OF CHIRAL CATALYSTS AND THEIR SALTS SCINOPHARM TAIWAN LTD (TW) 2017-09-13 EP disclosed
CN-103974932-B Preparation method of chiral catalyst and salt thereof SCINOPHARM TAIWAN, LTD. (CN) 2016-05-18 CN disclosed
US-8859765-B2 Process for the manufacture of chiral catalysts and their salts SCINOPHARM TAIWAN, LTD. (TW) 2014-10-14 US disclosed
CN-103974932-A Preparation method of chiral catalyst and salt thereof SCINOPHARM TAIWAN LTD 2014-08-06 CN disclosed
US-8563786-B2 Method for producing optically active alcohol MITSUI CHEMICALS, INC. (JP) 2013-10-22 US disclosed
US-20130150574-A1 PROCESS FOR THE MANUFACTURE OF CHIRAL CATALYSTS AND THEIR SALTS SCINOPHARM TAIWAN, LTD. (TW) 2013-06-13 US disclosed
US-20120088938-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2012-04-12 US disclosed
EP-2412694-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL Mitsui Chemicals, Inc. (JP) 2012-02-01 EP disclosed
US-7592487-B2 Chiral tertiary aminoalkylnaphthols THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2009-09-22 US disclosed
US-7592487-B2 Chiral tertiary aminoalkylnaphthols THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2009-09-22 US disclosed
US-20080045757-A1 Chiral Tertiary Aminoalkylnaphthols THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2008-02-21 US disclosed
US-20080045757-A1 Chiral Tertiary Aminoalkylnaphthols THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130150574-A1 PROCESS FOR THE MANUFACTURE OF CHIRAL CATALYSTS AND THEIR SALTS TST, TMT1A, MPST LMNA 4802/4885MLKL 4595/4885SMN1; SMN2 3491/4885
US-20080045757-A1 Chiral Tertiary Aminoalkylnaphthols ALDH7A1, ADH5, ALDH1A1 LMNA 3053/4885MLKL 4852/4885SMN1; SMN2 4808/4885
US-20120088938-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL ADH1A, ADH1C, FHIT LMNA 1422/4885MLKL 2292/4885SMN1; SMN2 4362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.